Tanvex BioPharma, Inc. (TPE:6541)

Tanvex BioPharma Statistics

Total Valuation

TPE:6541 has a market cap or net worth of TWD 14.80 billion. The enterprise value is 14.96 billion.

Market Cap	14.80B
Enterprise Value	14.96B

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TPE:6541 has 264.82 million shares outstanding. The number of shares has increased by 48.86% in one year.

Current Share Class	264.82M
Shares Outstanding	264.82M
Shares Change (YoY)	+48.86%
Shares Change (QoQ)	+7.30%
Owned by Insiders (%)	1.15%
Owned by Institutions (%)	1.84%
Float	109.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	65.84
PB Ratio	2.47
P/TBV Ratio	5.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.02
EV / Sales	66.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.04

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.26.

Current Ratio	2.97
Quick Ratio	2.31
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-1.14
Interest Coverage	-26.70

Financial Efficiency

Return on equity (ROE) is -37.98% and return on invested capital (ROIC) is -15.61%.

Return on Equity (ROE)	-37.98%
Return on Assets (ROA)	-14.47%
Return on Invested Capital (ROIC)	-15.61%
Return on Capital Employed (ROCE)	-17.27%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	200
Asset Turnover	0.04
Inventory Turnover	1.55

Taxes

Income Tax	-3.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.36% in the last 52 weeks. The beta is -0.06, so TPE:6541's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-22.36%
50-Day Moving Average	55.36
200-Day Moving Average	57.68
Relative Strength Index (RSI)	55.05
Average Volume (20 Days)	501,372

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6541 had revenue of TWD 224.83 million and -1.36 billion in losses. Loss per share was -6.18.

Revenue	224.83M
Gross Profit	-195.55M
Operating Income	-1.29B
Pretax Income	-1.36B
Net Income	-1.36B
EBITDA	-1.13B
EBIT	-1.29B
Loss Per Share	-6.18

Balance Sheet

The company has 1.39 billion in cash and 1.55 billion in debt, giving a net cash position of -153.42 million or -0.58 per share.

Cash & Cash Equivalents	1.39B
Total Debt	1.55B
Net Cash	-153.42M
Net Cash Per Share	-0.58
Equity (Book Value)	6.00B
Book Value Per Share	22.66
Working Capital	1.37B

Cash Flow

In the last 12 months, operating cash flow was -1.12 billion and capital expenditures -232.06 million, giving a free cash flow of -1.36 billion.

Operating Cash Flow	-1.12B
Capital Expenditures	-232.06M
Free Cash Flow	-1.36B
FCF Per Share	-5.12

Margins

Gross Margin	-86.98%
Operating Margin	-574.68%
Pretax Margin	-605.29%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6541 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.86%
Shareholder Yield	-48.86%
Earnings Yield	-9.17%
FCF Yield	-9.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.

Last Split Date	Mar 2, 2023
Split Type	Reverse
Split Ratio	0.3335779572

Scores

TPE:6541 has an Altman Z-Score of 0.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.67
Piotroski F-Score	3